GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » Cyclically Adjusted PS Ratio

ITGR (Integer Holdings) Cyclically Adjusted PS Ratio : 2.58 (As of May. 30, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Integer Holdings Cyclically Adjusted PS Ratio?

As of today (2025-05-30), Integer Holdings's current share price is $118.76. Integer Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $45.97. Integer Holdings's Cyclically Adjusted PS Ratio for today is 2.58.

The historical rank and industry rank for Integer Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

ITGR' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.71   Med: 2.17   Max: 3.17
Current: 2.6

During the past years, Integer Holdings's highest Cyclically Adjusted PS Ratio was 3.17. The lowest was 0.71. And the median was 2.17.

ITGR's Cyclically Adjusted PS Ratio is ranked worse than
55.21% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 2.23 vs ITGR: 2.60

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Integer Holdings's adjusted revenue per share data for the three months ended in Mar. 2025 was $12.896. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $45.97 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Integer Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Integer Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integer Holdings Cyclically Adjusted PS Ratio Chart

Integer Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.41 2.32 1.72 2.34 2.95

Integer Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.69 2.63 2.92 2.95 2.57

Competitive Comparison of Integer Holdings's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Integer Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integer Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Integer Holdings's Cyclically Adjusted PS Ratio falls into.


;
;

Integer Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Integer Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=118.76/45.97
=2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integer Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Integer Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=12.896/134.9266*134.9266
=12.896

Current CPI (Mar. 2025) = 134.9266.

Integer Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 6.647 100.684 8.908
201509 5.546 100.392 7.454
201512 10.883 99.792 14.715
201603 10.816 100.470 14.525
201606 11.323 101.688 15.024
201609 11.125 101.861 14.736
201612 1.528 101.863 2.024
201703 11.137 102.862 14.609
201706 8.784 103.349 11.468
201709 8.895 104.136 11.525
201712 9.334 104.011 12.108
201803 9.019 105.290 11.558
201806 9.611 106.317 12.197
201809 9.472 106.507 11.999
201812 9.174 105.998 11.678
201903 9.541 107.251 12.003
201906 9.518 108.070 11.883
201909 9.181 108.329 11.435
201912 9.841 108.420 12.247
202003 9.917 108.902 12.287
202006 7.248 108.767 8.991
202009 7.133 109.815 8.764
202012 8.118 109.897 9.967
202103 8.752 111.754 10.567
202106 9.383 114.631 11.044
202109 9.174 115.734 10.695
202112 9.405 117.630 10.788
202203 9.336 121.301 10.385
202206 10.497 125.017 11.329
202209 10.280 125.227 11.076
202212 9.796 125.222 10.555
202303 11.282 127.348 11.953
202306 11.876 128.729 12.448
202309 11.749 129.860 12.207
202312 11.899 129.419 12.405
202403 11.654 131.776 11.933
202406 12.277 132.554 12.497
202409 12.054 133.029 12.226
202412 12.392 133.157 12.557
202503 12.896 134.927 12.896

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Integer Holdings  (NYSE:ITGR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Integer Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Integer Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Integer Holdings Business Description

Traded in Other Exchanges
N/A
Address
5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
Executives
Joseph W Dziedzic director 1801 BAYBERRY COURT, RICHMOND VA 23226
Jean M. Hobby director 10000 WEHRLE DRIVE, CLARENCE NY 14031
Martin C Maxwell director PARKER HANNIFIN CORPORATION, 6035 PARKLAND BLVD, CLEVELAND OH 44124
John A Harris officer: VP, Operations Cardio & Vascul 10000 WEHRLE DRIVE, CLARENCE NY 14031
James F. Hinrichs director 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Payman Khales officer: President, C&V 10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn officer: SVP, Strategy and Business Dev 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Tommy P Thomas officer: VP, Corporate Controller 10000 WEHRLE DRIVE, CLARENCE NY 14031
Donald J Spence director C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jim Stephens officer: President, CRM & Neuro 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith officer: VP, Interim CFO 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Pamela G Bailey director 1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Marshall Mcalister C Ii officer: SVP, Gen Counsel & Secretary 1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226